CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 4.29: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.60%
Annual Rate
CNY 0.32Paid annual
Payout Ratio
37.1%Sustainable
Payback Period
58.0 yr
Last Ex-Dividend
Jun 5, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.40BCNY657.48M · vs all stocks (USD)
Trailing P/E
26.74xRevenue (TTM)
911.15MCNY136.01M · vs all stocks (USD)
Profit Margin
22.41%Beta
0.5500xvs all stocks
52-Week Change
-28.33%vs all stocks
Market Capitalization
4.40BCNY657.48M · vs all stocks (USD)
Enterprise Value
5.62BCNY838.81M · vs all stocks (USD)
Trailing P/E
26.74xForward P/E
15.57xPrice to Sales (TTM)
5.95xPrice to Book (MRQ)
4.74xEnterprise to Revenue
6.17xEnterprise to EBITDA
16.30xGross Margin
57.68%Profit Margin
22.41%Operating Margin
31.13%Return on Assets (TTM)
8.89%Return on Equity (TTM)
19.11%Revenue (TTM)
911.15MCNY136.01M · vs all stocks (USD)
Revenue per Share (TTM)
4.13CNYUpdated Sep 22, 2026Quarterly Revenue Growth
71.60%Gross Profit (TTM)
520.99MCNY77.77M · vs all stocks (USD)
EBITDA (TTM)
279.19MCNY41.67M · vs all stocks (USD)
Net Income (TTM)
204.16MCNY30.48M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
64.50%Operating Cash Flow (TTM)
184.01MCNY27.47M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-63.01MCNY-9.41M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.3200CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
1.60%vs all stocks
Payout Ratio
37.08%Revenue
741.46MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
313.97MCNYFY2025 · Dec 31, 2025Gross Profit
427.49MCNYFY2025 · Dec 31, 2025Operating Income
235.34MCNY35.13M · vs all stocks (USD)
Pre-tax Income
189.13MCNYFY2025 · Dec 31, 2025Income Tax Expense
31.24MCNYFY2025 · Dec 31, 2025Net Income
157.89MCNYFY2025 · Dec 31, 2025EBIT
204.27MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
279.19MCNYFY2025 · Dec 31, 2025Research & Development
54.91MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
89.96MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.68MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.50MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
15.14MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.7143CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7143CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
221.09MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
221.09MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
157.89MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
34.44KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
43.83MCNYFY2025 · Dec 31, 2025Free Cash Flow
-101.84MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
253.09MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
157.89MCNYFY2025 · Dec 31, 2025Other Non-cash Items
19.77MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-79.14MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-54.69MCNYFY2025 · Dec 31, 2025Capital Expenditures
-145.67MCNYFY2025 · Dec 31, 2025Net Acquisitions
1.66MCNYFY2025 · Dec 31, 2025Purchase of Investments
-66.00MCNYFY2025 · Dec 31, 2025Sale of Investments
19.61MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-190.40MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
437.91MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-413.03MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-36.00MCNYFY2025 · Dec 31, 2025Other Financing Charges
71.45MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
60.33MCNYFY2025 · Dec 31, 2025Shares Outstanding
220.34MSharesUpdated Sep 22, 2026Float Shares
136.52MSharesUpdated Sep 22, 2026% Held by Insiders
48.24%vs all stocks
% Held by Institutions
5.49%vs all stocks
Total Cash (MRQ)
352.71MCNY52.65M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.60CNYUpdated Sep 22, 2026Total Debt (MRQ)
672.92MCNY100.45M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5883xCurrent Ratio (MRQ)
1.97xBook Value per Share (MRQ)
5.19CNYUpdated Sep 22, 2026Total Assets
1.93BCNY288.77M · vs all stocks (USD)
Total Current Assets
881.43MCNYFY2025 · Dec 31, 2025Total Liabilities
876.93MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.05BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
250.41MCNYFY2025 · Dec 31, 2025Total Current Liabilities
626.52MCNYFY2025 · Dec 31, 2025Cash
278.09MCNYFY2025 · Dec 31, 2025Cash Equivalents
2.96MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
281.05MCNYFY2025 · Dec 31, 2025Other Short-term Investments
20.25MCNYFY2025 · Dec 31, 2025Accounts Receivable
147.24MCNYFY2025 · Dec 31, 2025Inventory
336.17MCNYFY2025 · Dec 31, 2025Accounts Payable
99.57MCNYFY2025 · Dec 31, 2025Short-term Debt
384.97MCNYFY2025 · Dec 31, 2025Other Current Liabilities
61.03KCNYFY2025 · Dec 31, 2025Long-term Debt
150.16MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
10.98MCNYFY2025 · Dec 31, 2025Common Stock (Book)
157.39MCNYFY2025 · Dec 31, 2025Retained Earnings
534.08MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.06BCNY157.87M · vs all stocks (USD)
52-Week Low
19.79CNYUpdated Sep 22, 202652-Week High
33.21CNYUpdated Sep 22, 202652-Week Change
-28.33%vs all stocks
Beta
0.5500xvs all stocks
50-Day MA
24.72CNYUpdated Sep 22, 2026200-Day MA
26.28CNYUpdated Sep 22, 2026Avg 10-Day Volume
4.23MSharesUpdated Sep 22, 2026Avg 30-Day Volume
7.02MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.9200CNYUpdated Sep 22, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.29: safe zoneNotable
Altman Z-Score: 4.29
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Jinhe Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jiangsu Lianhuan Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Henan Taloph Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nuvectis Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Kinetic Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Senores Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Climb Biotherapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Xiangxue Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zevra Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Fuan Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Triveni Engineering & Industries Ltd.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedPrice Below Mean With Profitability And Book Value
Shenzhen Liande Automatic Equipment Co., Ltd.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedPrice Below Mean With Profitability And Book Value
Hubei Xiangyuan New Material Co., Ltd.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedPrice Below Mean With Profitability And Book Value